Synthesis Capital, the one-year-old London-based food technology and alternative protein investor, closed its first fund with over $300 million in capital commitments.

The firm is led by former CPT Capital investors Costa Yiannoulis and Rosie Wardle, who have invested in the sector since its nascency in 2014, and biologist David Welch, and supports startups leveraging high tech to solve global food system challenges across the food value chain.